GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theriva Biologics Inc (FRA:SFY) » Definitions » Accumulated other comprehensive income (loss)

Theriva Biologics (FRA:SFY) Accumulated other comprehensive income (loss) : €-0.49 Mil (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Theriva Biologics Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Theriva Biologics's Accumulated other comprehensive income (loss) for the quarter that ended in Mar. 2024 was €-0.49 Mil.

Theriva Biologics's quarterly Accumulated other comprehensive income (loss) increased from Sep. 2023 (€-0.99 Mil) to Dec. 2023 (€0.03 Mil) but then declined from Dec. 2023 (€0.03 Mil) to Mar. 2024 (€-0.49 Mil).

Theriva Biologics's annual Accumulated other comprehensive income (loss) declined from Dec. 2021 (€0.00 Mil) to Dec. 2022 (€-0.64 Mil) but then increased from Dec. 2022 (€-0.64 Mil) to Dec. 2023 (€0.03 Mil).


Theriva Biologics Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Theriva Biologics's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theriva Biologics Accumulated other comprehensive income (loss) Chart

Theriva Biologics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accumulated other comprehensive income (loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - -0.64 0.03

Theriva Biologics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.29 -0.33 -0.99 0.03 -0.49

Theriva Biologics Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.


Theriva Biologics Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Theriva Biologics's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


Theriva Biologics (FRA:SFY) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theriva Biologics Inc (FRA:SFY) » Definitions » Accumulated other comprehensive income (loss)
Traded in Other Exchanges
Address
9605 Medical Center Drive, Suite 270, Rockville, MD, USA, 20850
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11, leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

Theriva Biologics (FRA:SFY) Headlines

From GuruFocus

SOFI WEALTH, LLC Goes on Buying Spree in 2nd Quarter

By GuruFocus Research GuruFocus Editor 07-25-2022